All Stories

  1. Bromelain and N-acetylcysteine in treatment of gastrointestinal cancer

    Article • Cancer Research, August 2015, American Association for Cancer Research (AACR)

    Dr Samar Masoumi-Moghaddam

  2. P3.04 * Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer

    Article • Annals of Oncology, March 2015, Oxford University Press (OUP)

    Dr Samar Masoumi-Moghaddam

  3. P5.10 * Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells: significance of combination therapy

    Article • Annals of Oncology, March 2015, Oxford University Press (OUP)

    Dr Samar Masoumi-Moghaddam

  4. Pseudomyxoma peritonei: current chemotherapy and the need for mucin-directed strategies

    Article • Expert Opinion on Orphan Drugs, January 2015, Informa Healthcare

    Dr Samar Masoumi-Moghaddam

  5. 188: Bromelain and N-acetylcysteine induce cytotoxic effects and reduce the expression of mucin in mucin-producing carcinoma cell lines of gastrointestinal origin

    Article • European Journal of Cancer, July 2014, Elsevier

    Dr Samar Masoumi-Moghaddam

  6. 187: The expression of the human Sprouty protein-1 (hSpry1) inversely correlates with proliferation, migration and invasion of the SKOV-3 and 1A9 human ovarian cancer cells

    Article • European Journal of Cancer, July 2014, Elsevier

    Dr Samar Masoumi-Moghaddam

  7. The expression of the Sprouty 1 protein inversely correlates with growth, proliferation, migration and invasion of ovarian cancer cells

    Article • Journal of Ovarian Research, June 2014, Springer Science + Business Media

    Dr Samar Masoumi-Moghaddam

  8. Secreted mucins in pseudomyxoma peritonei: pathophysiological significance and potential therapeutic prospects

    Article • Orphanet Journal of Rare Diseases, May 2014, Springer Science + Business Media

    Dr Samar Masoumi-Moghaddam

  9. The developing story of Sprouty and cancer

    Article • Cancer and Metastasis Reviews, April 2014, Springer Science + Business Media

    Dr Samar Masoumi-Moghaddam

  10. Cytotoxic effects of bromelain in human gastrointestinal carcinoma cell lines (MKN45, KATO-III, HT29-5F12, and HT29-5M21)

    Article • OncoTargets and Therapy, April 2013, Taylor & Francis

    Dr Samar Masoumi-Moghaddam, Dr Krishna Pillai, David Morris

  11. Utility of Vascular Endothelial Growth Factor Inhibitors in the Treatment of Ovarian Cancer: From Concept to Application

    Article • Journal of Oncology, January 2012, Hindawi Publishing Corporation

    Dr Samar Masoumi-Moghaddam

  12. Initial Report on Differential Expression of Sprouty Proteins 1 and 2 in Human Epithelial Ovarian Cancer Cell Lines

    Article • Journal of Oncology, January 2012, Hindawi Publishing Corporation

    Dr Samar Masoumi-Moghaddam

  13. The Critical Role of Vascular Endothelial Growth Factor in Tumor Angiogenesis

    Article • Current Cancer Drug Targets, January 2012, Bentham Science Publishers

    Dr Samar Masoumi-Moghaddam

  14. Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer

    Article • Cancer and Metastasis Reviews, November 2011, Springer Science + Business Media

    Dr Samar Masoumi-Moghaddam